OTCMKTS:ARPO - Aerpio Pharmaceuticals Price Target & Analyst Ratings

+0.01 (+1.61 %)
(As of 08/18/2019 04:00 PM ET)
Today's Range
Now: $0.63
50-Day Range
MA: $0.80
52-Week Range
Now: $0.63
Volume64,000 shs
Average Volume313,128 shs
Market Capitalization$25.57 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Aerpio Pharmaceuticals (OTCMKTS:ARPO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Aerpio Pharmaceuticals in the last 12 months. Their average twelve-month price target is $6.3333, suggesting that the stock has a possible upside of 905.29%. The high price target for ARPO is $10.00 and the low price target for ARPO is $1.00. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.252.402.403.00
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.3333$7.25$9.25$9.25
Price Target Upside: 905.29% upside632.32% upside798.06% upside168.12% upside

Aerpio Pharmaceuticals (OTCMKTS:ARPO) Consensus Price Target History

Aerpio Pharmaceuticals (OTCMKTS:ARPO) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
8/9/2019HC WainwrightReiterated RatingHold$1.00View Rating Details
3/18/2019GuggenheimDowngradeBuy ➝ NeutralView Rating Details
3/18/2019National SecuritiesDowngradeBuy ➝ NeutralView Rating Details
3/5/2019Cantor FitzgeraldSet Price TargetBuy$8.00View Rating Details
7/23/2018Needham & Company LLCInitiated CoverageBuy$10.00View Rating Details
(Data available from 8/18/2017 forward)
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel